rna universal messenger gene expression underlie cell identity cell state biological process across life span specie cellreadr enable celltypebased comparative evolutionary approach discover general biological principle accelerate development disease model celltype resolution especially use human cell tissue understand aetiology mechanism capacity flexibility programme cellular physiology cellreadr facilitate nextgeneration precision diagnostic therapeutic approach detect cancer cell use rna marker eliminate induce program cell death recruit immune cells46 whereas gene edit rna editingbased therapeutic approaches38,47 focus almost exclusively correct monogenic disease mutations48,49 many complex disorder neuropsychiatric developmental disorder result multigenic predisposition affect functional wire brain circuit may correct gene transcript edit modify tune affect cell type circuit rational approach treat conditions50 synergizing genome transcriptome engineer technology cellreadr facilitate research towards elucidate principle biological information flow genotype phenotype across cell type make possible new generation programmable cellspecific rna medicine construct generate use standard molecular clone procedure vector backbone linearize use restriction digestion dna fragment insert generate use pcr gblock synthesis integrate dna technology information plasmid include supplementary table 1. sesrna insert generate gblock synthesis integrate dna technology sesrna sequence use study include supplementary table 2. hela cell line obtain laboratory a. krainer mouse neuroblastoma neuro2a n2a cell purchase milliporesigma catalogue cat 89121404. hek293t kpc1242 cell line obtain laboratory d. fearon cell line test negative mycoplasma contamination hek293t hela n2a cell line culture dulbecco 's modify eagle medium corn 10013cv 10 fetal bovine serum fbs gibco 16000036 5 co 37 ¡ãc 1 penicillinstreptomycin add medium cell transfected lipofectamine 2000 invitrogen 11668019 dna transfection reagent accord manufacturer 's instruction interferon treatment medium contain 1 nm recombinant mouse ifn¦Â rd 8234mb use change every 24 h transfection process tetracycline treatment medium contain indicate tetracycline concentration use 24 h transfection replace tetracyclinefree medium 48 h analysis apoptosis assay cell incubate 72 h transfection realtimeglo annexin v apoptosis necrosis assay promega ja1011 use quantify apoptosis level pcr genomic dna use primer dyrk1a forward ggagctggtctgttggagaa reverse tcccaatccataatcccacgtt use amplify cas9 target region heterogeneous population modify unmodified cell pcr product reannealed slowly generate heteroduplexes reannealed heteroduplexes cleave surveyor nuclease whereas homoduplexes leave intact altr genome edit detection kit idt cas9mediated cleavage efficiency percentage indels calculate base fraction cleave dna six twentyweekold male female mouse use study mouse house standard laboratory condition specificpathogenfree cage animal room constant temperature 1923 ¡ãc regulate humidity 12 h:12 h light dark cycle receive standard laboratory chow water ad libitum maximum five mouse per cage wildtype mouse purchase jackson laboratory c57bl6j 000664. fezf2creer rosa26loxpstoploxph2bgfp mouse describe previously label fezf2 cortical pyramidal neuron 200 mg kg tamoxifen t56648 sigma administer intraperitoneal injection two day aav injection long evans rat rattus norvegicus age 12 week 50250 g obtain charles river rat maintain 12 h:12 h light dark cycle receive standard laboratory chow water ad libitum one animal per cage animal maintenance experimental procedure perform accord duke university irb protocol a2412012 mouse cold spring harbor laboratory irb protocol 18151 mouse duke university irb protocol a0591903 rat statistical method use predetermine sample size experiment randomize investigator blind allocation experiment outcome assessment experimental procedure carry accordance nih guideline approve institutional animal care use committee cold spring harbor laboratory duke university adar1knockout cell line generate via crisprcas9 genome edit guide rna grnas clone pspcas9 bb2apuro px459 addgene 62988. grna sequence 5 ggatactattcaagtcatctggg 3 grna1 5 gttatttgaggcatttgatg 3 grna2 brief adar1knockout cell generate two grnas target exon 2 share p110 p150 isoforms adar1 hek293t cell seed 6well plate transfected 1 ¦Ìg mixture px459grna1 px459grna2 use lipofectamine 2000 thermo fisher scientific cat 11668019. next day medium contain transfection reagent remove replace fresh medium supplement puromycin final concentration 2 ¦Ìg ml fresh medium puromycin replace old medium every two day three time remain cell puromycin selection collect tryple gibco cat 12605036 distribute 96well plate 12 cell per well expand single clone screen adar1 deficiency western blot disruption adar1 genomic locus confirm sanger sequence two day transfection cell collect tryple gibco 12605036 distribute 96well roundbottom plate centrifuge 500 rpm 1 min 4 ¡ãc supernatant remove cell resuspend 1 paraformaldehyde pfa buffer incubate 4 ¡ãc overnight longer time cell resuspend 200 ¦Ìl flow cytometry stain buffer invitrogen 00422226 analysis use lsr fortessa bd bioscience fortessa operate facsdiva bd bioscience software data analysis perform flowjo v10 flowjo sort cell submit procedure flow cytometry analysis without 1 pfa treatment process use bd facsaria bd bioscience assay cellreadr efficiency fluorescence reporter gene hek293t cell hek293t adar1knockout cell first seed 24well plate 24 h cell cotransfected 1.5 ¦Ìg plasmid total fortyeight hour transfection cell collect fix 1 pfa prepare facs analysis calculate cellreadr efficiency facs data cell readr vector gate accord fluorescent protein expression example bfp fig 1bd efficiency calculate ratio doublepositive cell express efrna target rna total number cell express target rna within gate spacer fluorescent protein fig 1h 2 ratio calculate directly ratio doublepositive cell express efrna target rna among cell express target rna control cellreadr efficiency calculate percentage efrnaexpressing cell among count cell use follow procedure sesrna design 1 sesrna complementary antisense specific cellular cod noncoding rna sequence 2 optimal length sesrna 200300 nt 3 readrrna consist sesrna efrna arrange continuous translation read frame 4 one stop codon tag place near centre sesrna range 80 220 nt 5 end 5 find 5'cca3 sequence target rna complementary 5'tgg3 sequence sesrna replace 5'tgg3 5'tag3 ac mismatch introduce sesrna base pair target rna 6 ensure stop codon sesrna tag taa tga sequence sesrna convert gag gaa gga respectively preferably convert stop codon near 10 bp tag define step 5 7 atg initiation codon tag define step 5 exclude possibility unintended translation initiation 8 sesrnas direct region cellular transcript include exon intron utrs mature mrna splice 9 avoid sesrna complex secondary structure sesrna design also facilitate use online tool cellreadr portal \<SEP>0